白色念珠菌ALS基因家族在生物膜形成过程中的差异表达

口腔医学研究 ›› 2015, Vol. 31 ›› Issue (10): 957-960.

白色念珠菌ALS基因家族在生物膜形成过程中的差异表达

何淼^1,2,宋光泰²,边专^1*

1. 武汉大学口腔医学院·口腔基础医学省部共建国家重点实验室培育基地和口腔生物医学教育部重点实验室;
2. 武汉大学口腔医院儿童口腔科湖北武汉 430079

收稿日期:2015-04-15 出版日期:2015-10-28 发布日期:2016-05-04
通讯作者: 边专,E-mail: bianzhuan@whu.edu.cn
作者简介:何淼(1980～ ),男,湖北武汉人,主治医师,博士,主要从事口腔生物学研究。
基金资助:
国家自然科学基金资助(编号:81300870)

Differential Expression of Candida Albicans ALS Gene Family During Biofilm Formation In Vitro

HE Miao^1,2, SONG Guang-tai², BIAN Zhuan^1*

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education and Department of Pediatric Dentistry, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China.

Received:2015-04-15 Online:2015-10-28 Published:2016-05-04

摘要/Abstract

摘要： 目的:研究白色念珠菌凝集素样粘附素(agglutinin-like sequence,ALS)基因家族成员在生物膜形成过程中的表达。方法:构建白色念珠菌标准株ATCC 10231和ATCC 90028体外生物膜模型,在生物膜形成的早期、中期和成熟期分别提取总RNA,应用半定量RT-PCR检测8个ALS基因的表达情况。结果:在生物膜形成的整个过程中,ALS1、ALS2、ALS3和ALS5持续高表达,是主要表达的粘附素基因,ALS6、ALS7、ALS9,尤其是ALS4表达较弱。ALS1、ALS2和ALS3在生物膜形成中期比在早期表达显著上调,但在成熟期表达下降。ALS基因家族成员的表达模式在菌株间无明显差异。结论:ALS1、ALS2、ALS3和ALS5在白色念珠菌体外生物膜形成过程中优势表达,对这些ALS基因的靶向抑制将为控制白色念珠菌生物膜相关疾病提供新的思路。

关键词: 白色念珠菌, ALS基因家族, 生物膜

Abstract: Objective: To investigate the differential expression of Candida albicans (C. albicans) agglutinin-like sequence (ALS) gene family during biofilm formation on biomaterial surfaces in vitro. Methods: The biofilm model of C. albicans standard strain ATCC 10231 and ATCC 90028 was established in vitro. Expression of the eight members in C. albicans ALS gene family was studied by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) of total RNA from the in vitro biofilm samples on biomaterial surfaces at three distinct developmental phases. Results: ALS1, ALS2, ALS3 and ALS5 transcripts were detected predominantly and consistently over time during biofilm formation. The expression of ALS6, ALS7 and ALS9, especially ALS4, was weak. Transcript amounts of ALS1, ALS2 and ALS3 were up-regulated significantly in intermediate phase and then down-regulated in maturation phase. Strain variability of ALS gene expression was not observed in this study. Conclusion: ALS1, ALS2, ALS3 and ALS5 are predominantly expressed during biofilm formation in vitro. Targeted inhibition of these ALS genes provides potential therapeutic targets to control C. albicans biofilm-associated diseases.

Key words: Candida albicans, Agglutinin-like sequence, Biofilm

中图分类号:

R780.1

何淼,宋光泰,边专. 白色念珠菌ALS基因家族在生物膜形成过程中的差异表达[J]. 口腔医学研究, 2015, 31(10): 957-960.

HE Miao, SONG Guang-tai, BIAN Zhuan. Differential Expression of Candida Albicans ALS Gene Family During Biofilm Formation In Vitro[J]. Journal of Oral Science Research, 2015, 31(10): 957-960.

参考文献

[1] Ramage G, Vandewalle K, Wickes BL, et al. Characteristics of biofilm formation by Candida albicans [J]. Rev Iberoam Micol, 2001, 18(4)∶163-170
[2] Sandven P. Epidemiology of candidemia [J]. Rev Iberoam Micol, 2000, 17(3)∶73-81
[3] Donlan RM. Biofilm formation: a clinically relevant microbiological process [J]. Clin Infect Dis, 2001, 33(8)∶1387-1392
[4] Douglas LJ. Candida biofilms and their role in infection [J]. Trends Microbiol, 2003, 11(1)∶30-36
[5] Kojic EM, Darouiche RO. Candida infections of medical devices [J]. Clin Microbiol Rev, 2004, 17(2)∶255-267
[6] Ramage G, Saville SP, Thomas DP, et al. Candida biofilms: an update [J]. Eukaryot Cell, 2005, 4(4)∶633-638
[7] Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance [J]. J Bacteriol, 2001, 183(18)∶5385-5394
[8] Calderone RA, Braun PC. Adherence and receptor relationships of Candida albicans [J]. Microbiol Rev, 1991, 55(1)∶1-20
[9] Mukherjee PK, Zhou G, Munyon R, et al. Candida biofilm: a well-designed protected environment [J]. Med Mycol, 2005, 43(3)∶191-208
[10] Hoyer LL. The ALS gene family of Candida albicans [J]. Trends Microbiol, 2001, 9(4)∶176-180
[11] Verstrepen KJ, Reynolds TB, Fink GR. Origins of variation in the fungal cell surface [J]. Nat Rev Microbiol, 2004, 2(7)∶533-540
[12] 亓庆国,胡涛,傅春华,等.附着状态对口腔白色念珠菌ALS基因mRNA的影响[J].华西口腔医学杂志,2005,23(3)∶233-236
[13] He M, Du M, Fan M, et al. In vitro activity of eugenol against Candida albicans biofilms [J]. Mycopathologia, 2007, 163(3)∶137-143
[14] Cheng G, Wozniak K, Wallig MA, et al. Comparison between Candida albicans agglutinin-like sequence gene expression patterns in human clinical specimens and models of vaginal candidiasis [J]. Infect Immun, 2005, 73(3)∶1656-1663
[15] Green CB, Cheng G, Chandra J, et al. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms [J]. Microbiology, 2004, 150(Pt2)∶267-275
[16] Richard ML, Nobile CJ, Bruno VM, et al. Candida albicans biofilm-defective mutants [J]. Eukaryot Cell, 2005, 4(8)∶1493-1502
[17] Marone M, Mozzetti S, De Ritis D, et al. Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample [J]. Biol Proced Online, 2001, 3∶19-25
[18] O'Connor L, Lahiff S, Casey F, et al. Quantification of ALS1 gene expression in Candida albicans biofilms by RT-PCR using hybridisation probes on the LightCycler [J]. Mol Cell Probes, 2005, 19(3)∶153-162
[19] 雷燕,李志强,周建业,等.16S rDNA相关技术在口腔细菌多态性研究中的应用[J].口腔医学研究,2014,30(12)∶1205-1207